Barclays
IMVT icon

Barclays’s Immunovant IMVT Stock Holding History

Barclays’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Sell
14,900
-217,426
-94% -$5.63M ﹤0.01% 3357
2025
Q4 		$5.91M Buy
232,326
+5,969
+3% +$133K ﹤0.01% 2086
2025
Q3 		$3.65M Sell
226,357
-44,993
-17% -$728K ﹤0.01% 2429
2025
Q2 		$4.34M Buy
271,350
+119,809
+79% +$1.81M ﹤0.01% 2250
2025
Q1 		$2.59M Sell
151,541
-158,789
-51% -$3.32M ﹤0.01% 2444
2024
Q4 		$7.69M Buy
310,330
+92,518
+42% +$2.62M ﹤0.01% 1783
2024
Q3 		$6.21M Buy
217,812
+119,372
+121% +$3.52M ﹤0.01% 1894
2024
Q2 		$2.6M Sell
98,440
-110,830
-53% -$3.15M ﹤0.01% 1952
2024
Q1 		$6.76M Buy
209,270
+41,277
+25% +$1.51M ﹤0.01% 1654
2023
Q4 		$7.08M Buy
+167,993
New +$6.18M ﹤0.01% 1809
2023
Q3 		– Sell
-2,286
Closed -$51.7K – 4646
2023
Q2 		$43.4K Buy
2,286
+2,200
+2,558% +$41K ﹤0.01% 3904
2023
Q1 		$1.33K Buy
+86
New +$1.49K ﹤0.01% 4913
2022
Q4 		– Sell
-6,000
Closed -$33K – 5315
2022
Q3 		$33K Buy
+6,000
New +$29.3K ﹤0.01% 3905

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return